Applications of Bioassay for Radioiodine, 54752-54753 [2014-21757]
Download as PDF
54752
Federal Register / Vol. 79, No. 177 / Friday, September 12, 2014 / Notices
APPENDIX A—IN THE MATTER OF JAMES CHAISSON: DEADLINES SPECIFIED IN INITIAL SCHEDULING ORDER—Continued
Deadline
Action
ISO section
Mid to late March 2015 * ............................
Evidentiary hearing .......................................................................................................
ISO IV.E
* These dates are subject to change and will be discussed during the second prehearing conference.
[FR Doc. 2014–21827 Filed 9–11–14; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2011–0224]
Applications of Bioassay for
Radioiodine
Nuclear Regulatory
Commission.
ACTION: Regulatory guide; issuance.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is issuing Revision 2
to Regulatory Guide (RG) 8.20,
‘‘Applications of Bioassay for Iodine125 and Iodine-131.’’ The title of this
regulatory guide has been changed to
‘‘Applications of Bioassay for
Radioiodine.’’ It describes methods and
criteria acceptable to the NRC staff for
the development and implementation of
a bioassay program by licensees
handling or processing unsealed
materials containing Iodine-123 (I–123),
Iodine-124 (I–124), Iodine-125 (I–125),
Iodine-129 (I–129), and Iodine-131 (I–
131), or a combination of these
radionuclides.
SUMMARY:
Please refer to Docket ID
NRC–2011–0224 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this action by the
following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2011–0224. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–287–3422;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual(s) listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the NRC
Library at https://www.nrc.gov/readingrm/adams.html. To begin the search,
select ‘‘ADAMS Public Documents’’ and
then select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
tkelley on DSK3SPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
17:58 Sep 11, 2014
Jkt 232001
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. Revision
2 of RG 8.20 is available in ADAMS
under Accession No. ML14064A060.
The regulatory analysis may be found in
ADAMS under Accession Number
ML14064A058.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
Regulatory guides are not
copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT:
Casper Sun, telephone: 301–251–7912,
email: casper.sun@nrc.gov; or Harriet
Karagiannis, telephone: 301–251–7477,
email: harriet.karagiannis@nrc.gov.
Both are staff of the Office of Nuclear
Regulatory Research, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001.
SUPPLEMENTARY INFORMATION:
I. Introduction
The NRC is issuing a revision to an
existing guide in the NRC’s ‘‘Regulatory
Guide’’ series. This series was
developed to describe and make
available to the public information
methods that are acceptable to the NRC
staff for implementing specific parts of
the agency’s regulations, techniques that
the staff uses in evaluating specific
problems or postulated accidents, and
data that the staff needs in its review of
applications for permits and licenses.
Revision 2 of RG 8.20 was issued with
a temporary identification as draft
regulatory guide (DG), DG–8050,
entitled, ‘‘Applications for Bioassay for
Radioiodine.’’ This guide was revised to
achieve better alignment with: (1) Part
20 of Title 10 of the Code of Federal
Regulations (10 CFR); and (2) the
internal dose assessment methods
recommended by the International
Commission on Radiological Protection
Publication 30, ‘‘Limits for Intakes of
Radionuclides by Workers.’’ The
content of the guide was also simplified
by removing the appendixes of the
previous version and including
pertinent information in the main
sections of the guide. Also, the title was
changed because the guide now
includes three more radioiodines (I–123,
I–124, and I–129), in addition to the two
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
radioiodines (I–125 and I–131) that were
included in the previous version.
II. Additional Information
This DG–8050 was published in the
Federal Register on September 26, 2011,
(76 FRN 59448) for a 60-day public
comment period. The public comment
period closed on November 22, 2011.
Public comments on DG–8050 and the
NRC staff’s responses to the public
comments are available in ADAMS
under Accession No. ML14064A061.
III. Congressional Review Act
This RG is a rule as defined in the
Congressional Review Act (5 U.S.C.
801–808). However, the Office of
Management and Budget has not found
it to be a major rule as defined in the
Congressional Review Act.
IV. Backfitting and Issue Finality
This RG describes methods that the
staff of the NRC considers acceptable for
the development and implementation of
bioassay programs for adult workers and
for licensees handling or processing
unsealed materials containing I–123,
I–124, I–125, I–129, and I–131 or a
combination of these radionuclides.
Some of the applicants and licensees to
whom this regulatory guide applies are
protected by backfitting provisions in
certain parts of 10 CFR Chapter I and/
or the issue finality provisions in 10
CFR part 52.
Issuance of this RG does not
constitute backfitting under 10 CFR
50.109, 10 CFR 70.76, 10 CFR 72.62, or
10 CFR 76.76, and is not inconsistent
with any issue finality provisions in 10
CFR part 52. As discussed in the
‘‘Implementation’’ section of this
regulatory guide, the NRC has no
current intention to impose this
regulatory guide on any licensees,
including holders of licenses protected
by the backfitting and issue finality
provisions listed above. Applicants for
the licenses listed above are not
protected by any backfitting and issue
finality provisions. Backfitting and the
issue finality provisions—with certain
exclusions discussed below—are not
intended to apply to every NRC action
which substantially changes the
expectations of current and future
applicants. The exceptions to the
general principle are applicable
whenever an applicant references a part
E:\FR\FM\12SEN1.SGM
12SEN1
Federal Register / Vol. 79, No. 177 / Friday, September 12, 2014 / Notices
52 license (e.g., an early site permit)
and/or NRC’s regulatory approval (e.g.,
a design certification rule) with
specified issue finality provisions. The
staff does not, at this time, intend to
impose the positions represented in this
RG in a manner that is inconsistent with
any part 52 issue finality provisions. If,
in the future, the staff seeks to impose
a position in the regulatory guide
section in a manner which does not
provide issue finality as described in the
applicable issue finality provision, then
the staff must address the criteria for
avoiding issue finality in that issue
finality provision.
Dated at Rockville, Maryland, this 8th day
of September, 2014.
For the Nuclear Regulatory Commission.
Thomas H. Boyce
Chief, Regulatory Guidance and Generic
Issues Branch, Division of Engineering, Office
of Nuclear Regulatory Research.
[FR Doc. 2014–21757 Filed 9–11–14; 8:45 am]
Week of September 22, 2014—Tentative
There are no meetings scheduled for the
week of September 22, 2014.
Week of September 29, 2014—Tentative
Dated: September 9, 2014.
Andrew Bates,
Senior Advisor, Office of the Secretary.
Week of October 6, 2014—Tentative
OFFICE OF PERSONNEL
MANAGEMENT
Tuesday, October 7, 2014
9:00 a.m. Briefing on the Status of
Near-Term Task Force
Recommendation 2.1 for Seismic
Hazard Reevaluations (Public
Meeting) (Contact: Nicholas
DiFrancesco, 301–415–1115)
This meeting will be webcast live at the
Web address—https://www.nrc.gov/.
Week of October 13, 2014—Tentative
NUCLEAR REGULATORY
COMMISSION
Wednesday, October 15, 2014
11:00 a.m. Discussion of Management
and Personnel Issues (Closed—Ex. 2
and 6)
Week of October 20, 2014—Tentative
Sunshine Act Meeting
Weeks of September 15, 22, 29,
October 6, 13, 20, 2014.
PLACE: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public and Closed.
DATES:
Week of September 15, 2014
Monday, September 15, 2014
1:30 p.m. NRC All Employees Meeting
(Public Meeting), Marriott Bethesda
North Hotel, 5701 Marinelli Road,
Rockville, MD 20852
Tuesday, September 16, 2014
9:50 a.m. Affirmation Session (Public
Meeting) (Tentative)
Final Rule: Economic Simplified Boiling
Water Reactor Design Certification
(Tentative)
This meeting will be webcast live at the
Web address—https://www.nrc.gov/.
10:00 a.m. Briefing on Project Aim
2020 (Closed—Ex. 2)
tkelley on DSK3SPTVN1PROD with NOTICES
Thursday, September 18, 2014
9:00 a.m. Briefing on Management of
Low-Level Waste, High-Level
Waste, and Spent Nuclear Fuel
(Public Meeting) (Contact: Cinthya
´
I. Roman, 301–287–9091)
This meeting will be webcast live at the
Web address—https://www.nrc.gov/.
VerDate Mar<15>2010
17:58 Sep 11, 2014
Jkt 232001
distribution, please contact the Office of
the Secretary, Washington, DC 20555
(301–415–1969), or send an email to
Patricia.Jimenez@nrc.gov or
Brenda.Akstulewicz@nrc.gov.
Thursday, October 2, 2014
10:00 a.m. Meeting with the Advisory
Committee on Reactor Safeguards
(ACRS) (Public Meeting) (Contact:
Ed Hackett, 301–415–7360)
This meeting will be webcast live at the
Web address—https://www.nrc.gov/.
BILLING CODE 7590–01–P
[NRC–2014–0001]
54753
There are no meetings scheduled for the
week of October 20, 2014.
*
*
*
*
*
The schedule for Commission meetings
is subject to change on short notice. For
more information or to verify the status
of meetings, contact Rochelle Bavol at
(301) 415–1651 or via email at
Rochelle.Bavol@nrc.gov.
*
*
*
*
*
The NRC Commission Meeting
Schedule can be found on the Internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
*
*
*
*
*
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings, or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.
braille, large print), please notify
Kimberly Meyer, NRC Disability
Program Manager, at 301–287–0727, by
videophone at 240–428–3217, or by
email at Kimberly.Meyer-Chambers@
nrc.gov. Determinations on requests for
reasonable accommodation will be
made on a case-by-case basis.
*
*
*
*
*
Members of the public may request to
receive this information electronically.
If you would like to be added to the
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
[FR Doc. 2014–21933 Filed 9–10–14; 4:15 pm]
BILLING CODE 7590–01–P
Submission for Review: Generic
Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery
U.S. Office of Personnel
Management.
ACTION: 60-day notice and request for
comments.
AGENCY:
The Office of Chief
Information Officer, Office of Personnel
Management (OPM) offers the general
public and other Federal agencies the
opportunity to comment on an
information collection request (ICR)
3206–0257, ‘‘Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.’’ As required
by the Paperwork Reduction Act of
1995, (Pub. L. 104–13, 44 U.S.C. chapter
35) as amended by the Clinger-Cohen
Act (Pub. L. 104–106), OPM is soliciting
comments for this collection.
DATES: Comments are encouraged and
will be accepted until November 12,
2014. This process is conducted in
accordance with 5 CFR 1320.1.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of the Chief Information
Officer, Records Management and Data
Policy, Office of Personnel Management,
1900 E. Street NW., Washington, DC
20415, Attention: Paperwork Reduction
Act Officer or sent by email to PRA@
opm.gov.
SUMMARY:
A
copy of this ICR, with applicable
supporting documentation, may be
obtained by contacting the Office of the
Chief Information Officer, Records
Management and Data Policy, Office of
Personnel Management, 1900 E. Street
NW., Washington, DC 20503, Attention:
Paperwork Reduction Act Officer or sent
by email to PRA@opm.gov.
SUPPLEMENTARY INFORMATION: The
proposed information collection activity
provides a means to garner qualitative
customer and stakeholder feedback in
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\12SEN1.SGM
12SEN1
Agencies
[Federal Register Volume 79, Number 177 (Friday, September 12, 2014)]
[Notices]
[Pages 54752-54753]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21757]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2011-0224]
Applications of Bioassay for Radioiodine
AGENCY: Nuclear Regulatory Commission.
ACTION: Regulatory guide; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing
Revision 2 to Regulatory Guide (RG) 8.20, ``Applications of Bioassay
for Iodine-125 and Iodine-131.'' The title of this regulatory guide has
been changed to ``Applications of Bioassay for Radioiodine.'' It
describes methods and criteria acceptable to the NRC staff for the
development and implementation of a bioassay program by licensees
handling or processing unsealed materials containing Iodine-123 (I-
123), Iodine-124 (I-124), Iodine-125 (I-125), Iodine-129 (I-129), and
Iodine-131 (I-131), or a combination of these radionuclides.
ADDRESSES: Please refer to Docket ID NRC-2011-0224 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this action by the
following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2011-0224. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section
of this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the NRC
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. Revision 2 of RG 8.20 is
available in ADAMS under Accession No. ML14064A060. The regulatory
analysis may be found in ADAMS under Accession Number ML14064A058.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
Regulatory guides are not copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT: Casper Sun, telephone: 301-251-7912,
email: casper.sun@nrc.gov; or Harriet Karagiannis, telephone: 301-251-
7477, email: harriet.karagiannis@nrc.gov. Both are staff of the Office
of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001.
SUPPLEMENTARY INFORMATION:
I. Introduction
The NRC is issuing a revision to an existing guide in the NRC's
``Regulatory Guide'' series. This series was developed to describe and
make available to the public information methods that are acceptable to
the NRC staff for implementing specific parts of the agency's
regulations, techniques that the staff uses in evaluating specific
problems or postulated accidents, and data that the staff needs in its
review of applications for permits and licenses.
Revision 2 of RG 8.20 was issued with a temporary identification as
draft regulatory guide (DG), DG-8050, entitled, ``Applications for
Bioassay for Radioiodine.'' This guide was revised to achieve better
alignment with: (1) Part 20 of Title 10 of the Code of Federal
Regulations (10 CFR); and (2) the internal dose assessment methods
recommended by the International Commission on Radiological Protection
Publication 30, ``Limits for Intakes of Radionuclides by Workers.'' The
content of the guide was also simplified by removing the appendixes of
the previous version and including pertinent information in the main
sections of the guide. Also, the title was changed because the guide
now includes three more radioiodines (I-123, I-124, and I-129), in
addition to the two radioiodines (I-125 and I-131) that were included
in the previous version.
II. Additional Information
This DG-8050 was published in the Federal Register on September 26,
2011, (76 FRN 59448) for a 60-day public comment period. The public
comment period closed on November 22, 2011. Public comments on DG-8050
and the NRC staff's responses to the public comments are available in
ADAMS under Accession No. ML14064A061.
III. Congressional Review Act
This RG is a rule as defined in the Congressional Review Act (5
U.S.C. 801-808). However, the Office of Management and Budget has not
found it to be a major rule as defined in the Congressional Review Act.
IV. Backfitting and Issue Finality
This RG describes methods that the staff of the NRC considers
acceptable for the development and implementation of bioassay programs
for adult workers and for licensees handling or processing unsealed
materials containing I-123, I-124, I-125, I-129, and I-131 or a
combination of these radionuclides. Some of the applicants and
licensees to whom this regulatory guide applies are protected by
backfitting provisions in certain parts of 10 CFR Chapter I and/or the
issue finality provisions in 10 CFR part 52.
Issuance of this RG does not constitute backfitting under 10 CFR
50.109, 10 CFR 70.76, 10 CFR 72.62, or 10 CFR 76.76, and is not
inconsistent with any issue finality provisions in 10 CFR part 52. As
discussed in the ``Implementation'' section of this regulatory guide,
the NRC has no current intention to impose this regulatory guide on any
licensees, including holders of licenses protected by the backfitting
and issue finality provisions listed above. Applicants for the licenses
listed above are not protected by any backfitting and issue finality
provisions. Backfitting and the issue finality provisions--with certain
exclusions discussed below--are not intended to apply to every NRC
action which substantially changes the expectations of current and
future applicants. The exceptions to the general principle are
applicable whenever an applicant references a part
[[Page 54753]]
52 license (e.g., an early site permit) and/or NRC's regulatory
approval (e.g., a design certification rule) with specified issue
finality provisions. The staff does not, at this time, intend to impose
the positions represented in this RG in a manner that is inconsistent
with any part 52 issue finality provisions. If, in the future, the
staff seeks to impose a position in the regulatory guide section in a
manner which does not provide issue finality as described in the
applicable issue finality provision, then the staff must address the
criteria for avoiding issue finality in that issue finality provision.
Dated at Rockville, Maryland, this 8th day of September, 2014.
For the Nuclear Regulatory Commission.
Thomas H. Boyce
Chief, Regulatory Guidance and Generic Issues Branch, Division of
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2014-21757 Filed 9-11-14; 8:45 am]
BILLING CODE 7590-01-P